The user facility reported to terumo cardiovascular systems that prior to cardiopulmonary bypass, during setup, the venous inlet of the oxygenator was dented.There was also a tear in the blue inlet port caps.No patient involvement as this occurred during setup.Product was changed out.Surgery as completed successfully without delay.
|
This follow-up report is submitted to the fda in accord with applicable regulations - and as indicated by terumo cardiovascular system in the initial report submitted to the fda on december 23, 2015.Upon further investigation of the reported event, the following information is new and/or changed: (date received by manufacturer).(indication that this is a follow-up report).(follow-up due to device evaluation).(device evaluated by manufacturer).(b)(4).The actual sample was visually inspected upon receipt, during which it was confirmed that there was damage to the blood inlet port of the oxygenator and to the cardiotomy port cap on the reservoir lid.No other damages were noted on the device.A review of the device history record revealed no anomalies.All units are 100% visually inspected during final assembly and packaging.The damage to the port and cap was most likely due to an extreme external force being applied to the product at some point after final release, during shipping and handling; however, a definitive root cause could not be determined.All available information has been placed on file in quality management for appropriate tracking, trending and follow up.
|